Tudor Investment Corp’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,680
Closed -$980K 2672
2024
Q2
$980K Sell
10,680
-161,556
-94% -$15M 0.01% 1470
2024
Q1
$15.9M Buy
172,236
+142,199
+473% +$13.3M 0.1% 205
2023
Q4
$2.86M Buy
+30,037
New +$2.81M 0.02% 927
2023
Q2
Sell
-27,747
Closed -$2.04M 2392
2023
Q1
$2.04M Buy
+27,747
New +$2.4M 0.03% 782
2022
Q1
Sell
-1,574
Closed -$255K 1966
2021
Q4
$255K Buy
+1,574
New +$253K ﹤0.01% 1961
2019
Q3
Sell
-10,217
Closed -$1.24M 1069
2019
Q2
$1.24M Sell
10,217
-32,911
-76% -$3.91M 0.04% 460
2019
Q1
$5.32M Buy
43,128
+12,258
+40% +$1.54M 0.22% 88
2018
Q4
$3.62M Buy
+30,870
New +$3.64M 0.07% 88
2018
Q3
Sell
-12,818
Closed -$1.09M 1070
2018
Q2
$1.09M Buy
12,818
+4,220
+49% +$310K 0.04% 410
2018
Q1
$519K Buy
+8,598
New +$490K 0.02% 558
2016
Q1
Sell
-6,400
Closed -$252K 1713
2015
Q4
$252K Sell
6,400
-1,357
-17% -$54.3K 0.01% 1317
2015
Q3
$295K Buy
+7,757
New +$327K 0.01% 1114
2015
Q2
Sell
-12,578
Closed -$337K 1472
2015
Q1
$337K Sell
12,578
-17,241
-58% -$486K 0.01% 978
2014
Q4
$875K Buy
29,819
+16,819
+129% +$415K 0.03% 405
2014
Q3
$262K Buy
+13,000
New +$251K 0.01% 1081

Other funds holding AMED

Tudor Investment Corp's AMED Position: Q3 2024 in Review

Tudor Investment Corp sold out of Amedisys (AMED) in Q3 2024, closing a stake of 10,680 shares — an estimated $980K sold.

Tudor Investment Corp first reported a position in AMED in Q3 2014 and held it in 15 quarters. The position peaked at $15.9M in Q1 2024. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Tudor Investment Corp reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 10,680 Amedisys shares in Q3 2024, an estimated $980K.
  • Tudor Investment Corp first reported a position in Amedisys in Q3 2014 and held it in 15 quarters.
  • Tudor Investment Corp's Amedisys position peaked at $15.9M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.